20 December 2024 | 35:00 min.
Webinar Series
Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12
Combination Products and Companion Diagnostics
The regulatory pathways for medicinal products (drugs) on the one hand and medical devices / in-vitro-diagnostics on the other are different and separate from each other. When a medicinal product is meant to be used in combination with a medical device, or when a diagnostic test needs to be performed to support the choice of the right medication, special rules apply that impact your regulatory strategy from the beginning. Dr Manja Epping and Christoph Behm will guide you through typical scenarios and strategic options.
In this series
Coffee Break Life Sciences | Overview page
Navigating the revised EU Urban Wastewater Treatment Directive | Coffee Break Life Sciences #1
17 January 2025
Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12
20 December 2024
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
19 November 2024
Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10
20 October 2024
Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9
27 September 2024
Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8
22 August 2024
Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7
18 July 2024
by Irina Rebin
Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6
26 June 2024
Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5
15 May 2024
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
by Irina Rebin
Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3
20 March 2024
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
23 February 2024
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30 January 2024
Related Insights
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10
